Regulation of regulatory T cells: Role of dendritic cells and toll-like receptors

Critical Reviews in Immunology

Volumn 26, Issue 4, 2006, Pages 291-305

  Kabelitz, Dieter ^a   Wesch, Daniela ^a   Oberg, Hans Heinrich ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

IL 6 receptor; T cell suppression; TLR ligands

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTING CELL; BONE MARROW CELL; CELL CONTACT; CELL MATURATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REGULATORY T LYMPHOCYTE; REVIEW; STEM CELL; TH1 CELL;

ANIMALS; DENDRITIC CELLS; HUMANS; LIGANDS; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTORS;

EID: 33747034337     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Möller G. Do suppressor cells exist? Scand J Immunol. 1988;27:247-50.
2. Sakaguchi S, Sakaguchi N, Asano M, Ithoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151-64.
3. Pernis B, Vogel HJ, editors. Regulatory T lymphocytes. New York: Academic Press; 1980.
4. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004; 22:531-62.
5. Brunkow ME, Gardner JC, Hjerrild KA, Paeper B, Clark JB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27:68-73.
6. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27:20-1.
7. + regulatory T cells. J Immunol. 2005;174:90-8.
8. Walsh PT, Taylor DK, Turka LA. Tregs and transplantation tolerance. J Clin Invest. 2004;114:1398-403.
9. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol. 2005;6:353-60.
10. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345-52.
11. Guernomonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol. 2002;20:621-67.
12. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003;21:685-711.
13. Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H. Immature, but not inactive: the tolerogenic function of dendritic cells. Immunol Cell Biol. 2002;80:477-83.
14. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5:987-95.
15. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335-76.
16. Schwartz RH. Natural regulatory T cells and selftolerance. Nat Immunol. 2005;6:327-30.
17. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol. 2003;3:199-210.
18. Weiner HL. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol Rev. 2001;182:207-14.
19. Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol. 2003;171:6323-7.
20. Höglund P. Induced peripheral regulatory T cells: the family grows larger. Eur J Immunol. 2006;36:264-6.
21. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subsets. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med. 1985;161:72-87.
22. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol. 1999;162:5317-26.
23. + regulatory T cells induced by an agonistic self-peptide. Nat Immunol. 2001;2:301-6.
24. + regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J Immunol. 2002;168:4399-405.
25. + T cell receptors. Immunity. 2004;21:267-77.
26. + regulatory T cells in human thymus. Nature. 2005;436:1181-5.
27. + regulatory T lymphoyctes. Eur J Immunol. 2005;35:3525-32.
28. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity. 2005;22:329-41.
29. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol. 2005;6:331-7.
30. Kumanogoh A, Wang X, Lee I, Watanabe C, Kamanaka M, Shi W, Yoshida K, Sato T, Habu S, Itoh M, Sakaguchi N, Sakaguchi S, Kikutani H. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol. 2001;166:353-60.
31. + immunregulatory T cells that control autoimmune diabetes. Immunity. 2000;12:431-40.
32. + regulatory T cell function. J Exp Med. 2002;196:851-7.
33. - T cells. J Clin Invest. 2003;112:1437-43.
34. - cells. Proc Natl Acad Sci U S A. 2005;102:4103-8.
35. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol. 2004;4:665-74.
36. + regulatory T cell function. Eur J Immunol. 2004;34:2480-8.
37. + T cell suppressor function. J Immunol. 2004;172:6519-23.
38. + T cells. Clin Immunol. 2005;115:10-8.
39. + regulatory T cells through GITR breaks immunological selftolerance. Nat Immunol. 2002;3:135-42.
40. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 2002;16:311-23.
41. Nocentini G, Riccardi C. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol. 2005;35:1016-22.
42. Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, Hipkiss EL, Ravi S, Kowalski J, Levitsky HI, Powell JD, Pardoll DM, Drake CG, Vignali DAA. Role of LAG-3 in regulatory T cells. Immunity. 2004;21:503-13.
43. Ronchetti S, Zollo O, Bruscoli S, Agostini M, Bianchini R, Nocentini G, Ayroldi E, Riccardi C. GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol. 2004;34:613-22.
44. Ronchetti S, Nocentini G, Riccardi C, Pandolfi PP. Role of GITR in activation response of T lymphocytes. Blood. 2002;100:350-2.
45. + T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med. 2002;196:1335-46.
46. + regulatory T cells. Trends Immunol. 2004;25:375-80.
47. Bour-Jourdan H, Bluestone JA. CD28 function: a balance of costimulatory and regulatory signals. J Clin Immunol. 2002;22:1-7.
48. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000;192:303-9.
49. Jago CB, Yates J, Camara NOS, Lechler RI, Lombardi G. Differential expression of CTLA-4 among T cell subsets. Clin Exp Immunol. 2004;136:463-71.
50. + regulatory T cells are dependent on CTLA-4 expression. Eur J Immunol. 2004;34:3485-96.
51. + regulatory T cells exert in vitro suppressive activity independent of CTLA-4. Int Immunol. 2005;17:421-7.
52. + regulatory T cells. Eur J Immunol. 2002;32:2888-96.
53. Zheng Y, Manzotti CN, Liu M, Burke F, Mead KI, Sansom DM. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol. 2004;172:2778-84.
54. Ndhlovo LC, Takeda I, Sugamuru K, Ishii N. Expanding role of T-cell costimulators in regulatory T-cell function: recent advances in accessory molecules expressed on both regulatory and nonregulatory T cells. Crit Rev Immunol. 2004;24:251-66.
55. - regulatory T cells. Proc Natl Acad Sci U S A. 2002;99:13031-6.
56. + T helper cells. Eur J Immunol. 2004;34:1303-11.
57. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, von Boehmer H, Buer J, Hansen W. Neuropilin: a surface marker of regulatory T cells. Eur J Immunol. 2004;34:623-30.
58. Firan M, Dhillon S, Estess P, Siegelman MH. Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood. 2006;107:619-27.
59. + regulatory T cells in inflamed synovia. J Exp Med. 2005;201:1793-803.
60. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-61.
61. + regulatory T cells. Nat Immunol. 2003;4:337-42.
62. Schubert LA, Jeffery EJ, Zhang Y, Ramsdell F, Ziegler SF. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem. 2001;276:37672-9.
63. Bettelli E, Dastrange M, Ouka M. Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A. 2005;102:5138-43.
64. Carson BD, Lopes JE, Soper DM, Ziegler SF. Insights into transcriptional regulation by FOXP3. Front Biosci. 2006;11:1607-19.
65. + T regulatory cells in humans. Hum Immunol. 2005;66:13-20.
66. + Tregs. J Clin Invest. 2005;115:3276-84.
67. + regulatory T cells at the single-cell level. Eur J Immunol. 2005;35:1681-91.
68. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol. 2005;6:338-44.
69. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, Santamaria P, Locksley RM, Krummel MF, Bluestone JA. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol. 2006;7:83-92.
70. + regulatory T cells is mediated by cell surface-bound transforming growth factor-β. J Exp Med. 2001;194:629-44.
71. + regulatory T cell activity in both humans and mice. J Immunol. 2004;172:834-42.
72. Ostroukhova M, Qi Z, Oriss TB, Dixon-McCarthy B, Ray P, Ray A. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-β. J Clin Invest. 2006;116:996-1004.
73. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol. 2005;174:1783-6.
74. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity. 2004;21:589-601.
75. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998;188:287-96.
76. Klein L, Khazaie K, von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci U S A. 2003;100:8886-91.
77. + regulatory T cells. J Exp Med. 2005;201:181-7.
78. -/- mice. J Immunol. 2004;173:1059-65.
79. Wohlfert EA, Gorelik L, Mittler R, Flavell RA, Clark RB. Cutting edge: deficiency in the E3 ubiquitin ligase cbl-b results in a multifunctional defect in T cell TGF-β sensitivity in vitro and in vivo. J Immunol. 2006;176:1316-20.
80. + T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc Natl Acad Sci U S A. 2003;100:10878-83.
81. Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, von Boehmer H, Khazaie K. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo. Proc Natl Acad Sci U S A. 2005;102:419-24.
82. + regulatory T cells. J Exp Med. 2005;201:737-46.
83. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811.
84. Martin E, O'Sullivan B, Low P, Thomas R. Antigenspecific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity. 2003;18:155-67.
85. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 2003;18:605-17.
86. + Tr cells. Blood. 2005;105:1162-9.
87. Rössner S, Voigtländer C, Wiethe C, Hänig J, Seifarth C, Lutz MB. Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro. Eur J Immunol. 2005;35:3533-44.
88. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 2006;66:1123-31.
89. Terness P, Chuang JJ, Opelz G. The immunoregulatory role of IDO-producing human dendritic cells revisited. Trends Immunol. 2006;27:68-73.
90. + regulatory T cells by antigen-processing dendritic cells. J Exp Med. 2003;198:235-47.
91. + regulatory cell activation and function by dendritic cells. Int Immunol. 2004;16:1769-80.
92. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005;6:1219-27.
93. + regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci U S A. 2006;103:2758-63.
94. + T cell-mediated suppression by dendritic cells. Science. 2003;299:1033-6.
95. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1-78.
96. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F. Principles of interleukin (IL)-6 type cytokine signalling and its regulation. Biochem J. 2003;374:1-20.
97. Matthews V, Schuster B, Schütze S, Bussmeyer I, Luwdig A, Hundhausen C, Sadowski T, Saftig P, Hartmann D, Kallen KJ, Rose-John S. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J Biol Chem. 2003;278:38829-39.
98. Rose-John S, Neurath MF. IL-6 trans-signaling: the heat is on. Immunity. 2004;20:2-4.
99. Fischer M, Goldschmitt J, Peschel C, Brakenhoff JP, Kallen KJ, Wollmer A, Grötzinger J, Rose-John S. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol. 1997;15:142-5.
100. high regulatory T cells. Int Immunol. 2006;18:555-63.
101. + Treg development and function during allergic airway inflammation in vivo. J Clin Invest. 2005;115:313-25.
102. Kubo T, Hatton RD, Oliver J, Liu X, Elson CO, Weaver CT. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J Immunol. 2004;173:7249-58.
103. Yang Y, Huang CT, Huang X, Pardoll DM. Persistent toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol. 2004;5:508-15.
104. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1 and IL-18 mediated function. Immunity. 1998;9:143-50.
105. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medhzitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol. 2001;2:947-50.
106. Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol. 2001;166:5688-94.
107. Pasare C, Medhzitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity. 2004;21:733-41.
108. Lang KS, Recher M, Junt T, Navarini AA, Harris NL, Freigang S, Odermatt B, Conrad C, Ittner LM, Bauer S, Luther SA, Uematsu S, Akira S, Hengartner H, Zinkernagel RM. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmne disease. Nat Med. 2005;11:138-45.
109. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol. 2002;168:4531-7.
110. + T cells. J Immunol. 2005;175:1551-7.
111. Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A. 2004;101:3029-34.
112. Wesch D, Beetz S, Oberg HH, Marget M, Krengel K, Kabelitz D. Direct costimulatory effect of TLR3 ligand poly(I:C) on human γδ T lymphocytes. J Immunol. 2006;176:1348-54.
113. + T cell survival. J Immunol. 2004;172:6065-73.
114. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med. 2003;197:403-11.
115. Sutmuller RP, den Brok MH, Kramer M, Bennink EJ, Toonen LW, Kullberg BJ, Joosten LA, Akira S, Netea MG, Adema GJ. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest. 2006;116:485-94.
116. Netea MG, Sutmuller R, Hermann C, van der Graaf CA. van der Meer JW, van Krieken JH, Hartung T, Adema G, Kullberg BJ. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol. 2004;172:3712-8.
117. + regulatory T cell function. Science. 2005;309:1380-4.
118. + T regulatory cells. J Immunol. 2005;175:8051-9.